Dr. Satoshi Namekawa's research focuses on understanding how epigenetic mechanisms control the development of sperm and eggs, which are crucial for reproduction. The lab investigates complex processes like spermatogenesis and oogenesis to uncover how these processes ensure the continuity of life from one generation to the next. Their findings hope to enhance our knowledge of germline biology and contribute to advancements in reproductive health.

Dr. Xiaodong Cheng's lab focuses on understanding how modifications to DNA and histones can affect gene expression. By studying the molecular mechanisms behind these epigenetic changes, the lab aims to uncover how transcription factors interact with DNA and how these processes can influence health and disease. This research is particularly relevant for developing new therapeutic strategies targeting gene regulation.

Dr. Tobias Volker Lanz's research lab at Stanford University focuses on understanding how the Epstein-Barr virus (EBV) contributes to autoimmune diseases like multiple sclerosis (MS). By characterizing EBV-infected B cells, the lab aims to uncover the mechanisms underlying EBV-related pathologies in MS and other autoimmune conditions. The lab employs innovative technologies to isolate and study these cells, which are crucial for advancing our knowledge of autoimmune disease mechanisms.

Dr. Renfeng Li's lab at the University of Pittsburgh focuses on understanding the Epstein-Barr virus (EBV), a virus linked to various cancers. The lab studies how the ASB13 protein influences the life cycle of EBV, particularly how it regulates viral replication and reactivation in B cells. Their research aims to uncover new therapeutic strategies for treating EBV-related diseases by targeting the virus's behavior in human cells.

Dr. Loren D. Erickson's lab explores how specific immune responses, particularly those involving IgE antibodies, affect cardiovascular health. Specifically, the research focuses on the connection between IgE sensitization to a mammalian sugar called alpha-gal and the development of atherosclerosis, a condition where arteries become clogged. Using both human studies and novel mouse models, the lab aims to uncover the mechanisms by which IgE influences plaque formation and stability in the arteries, which could lead to new insights into coronary artery disease.

Dr. Donna L. Farber's lab focuses on understanding how regulatory T cells (Tregs) contribute to immune memory and protection against viral infections in human tissues. They explore the unique roles of Tregs in maintaining tissue homeostasis and tolerance, investigating how these cells interact with other immune and structural cells. This research is crucial for developing therapies for autoimmune diseases and improving tissue repair and transplantation outcomes.

Dr. Haitao Wen's lab at Ohio State University focuses on understanding how a specific type of cell death, called ferroptosis, can be induced in cancer cells. The lab investigates how mitochondrial calcium signaling affects this process, especially in cancers that resist traditional therapies. By exploring the connections between cell death and immune response in tumors, the research aims to identify new ways to enhance cancer treatment.

Dr. Kristina M. Adams Waldorf's lab focuses on understanding how maternal viral infections, such as Zika virus, impact the developing fetal immune system and brain health. The lab uses advanced models to analyze how infections can influence immune programming and cellular responses in the fetus, with the aim of developing new therapeutic strategies for fetal protection against infection-induced damage.

Brian T. Fife's research lab at the University of Minnesota focuses on understanding type 1 diabetes, an autoimmune condition causing the destruction of insulin-producing cells. The lab studies how a diverse microbial environment can influence immune responses, potentially protecting against or triggering diabetes. Additionally, the lab is innovating ways to engineer regulatory T cells (Tregs) to specifically target and suppress the autoimmune response associated with this disease, aiming to develop effective therapies.

Dr. Martin Flajnik's lab focuses on understanding the evolution and function of the immune system, particularly how it has developed over millions of years. By studying sharks, which possess unique immune molecules, the lab aims to uncover foundational principles of immunity that may also apply to humans. The research combines biochemistry, structural biology, and immunological techniques to explore how these ancient immune components operate and their implications for human health.

Dr. Matthew J. Evans' lab at the Icahn School of Medicine focuses on understanding how certain viruses, particularly flaviviruses like Zika and dengue, evade the human immune system. By studying the nonstructural protein 5 (NS5) of these viruses, the lab aims to reveal mechanisms of viral replication and immune suppression. This knowledge is crucial for developing new antiviral treatments and vaccines.

Dr. Sarah Fortune's lab focuses on understanding how the bacterium Mycobacterium tuberculosis (Mtb) develops resilience to antibiotics, leading to treatment failures. The team investigates the genetic and molecular mechanisms that allow Mtb to survive antibiotic exposure and recover more effectively than usual. Ultimately, the lab aims to inform better treatment strategies for tuberculosis and enhance public health outcomes.

Dr. Daniela Frasca's research focuses on understanding how aging and HIV affect the immune system, specifically looking at the metabolic changes that occur in immune cells. The lab studies how these changes can lead to poorer immune responses and aims to develop strategies to improve immunity in aging individuals living with HIV. By exploring the links between metabolism, inflammation, and immune function, this research could help enhance the health of older adults with HIV.

Dr. Michael C. Lorenz's lab at the University of Texas Health Science Center Houston focuses on understanding how a bacterial peptide can inhibit the virulence of human fungal pathogens. Their research is particularly relevant as fungal infections become increasingly resistant to existing treatments. By studying the mechanisms of this peptide, the lab aims to develop new antifungal therapies that could significantly improve health outcomes for patients with serious fungal infections.

Dr. Maurizio Del Poeta's lab at Stony Brook University explores the biology of harmful fungi, particularly how they infect immunocompromised patients, such as those with HIV. The research focuses on understanding the immune response to fungal infections and developing novel antifungal treatments that target specific enzymes unique to fungi, which can help improve patient outcomes. By utilizing mouse models and high-throughput screening, the lab aims to provide new insights and therapeutic strategies against invasive fungal infections.

Dr. Robert Cramer's lab at Dartmouth College focuses on understanding and overcoming fungal infections, particularly those caused by the mold Aspergillus fumigatus, which can be deadly for immunocompromised patients. The lab develops new antifungal drugs that are effective against drug-resistant strains of moulds and studies how certain cancer therapies can influence fungal pathogenicity. They combine chemical biology, genetic analysis, and mouse models to tackle these pressing health issues.

Dr. Jorge E. Galan's research lab at Yale University focuses on understanding how the bacterium Salmonella affects host cells. By studying the ways that Salmonella uses specific proteins to manipulate cellular functions, the lab aims to uncover the secrets of how the bacteria survive and cause disease. This research could lead to new treatments and preventions for Salmonella infections, which pose a significant public health threat. The team investigates cellular signaling pathways and immune responses to advance our knowledge of host-pathogen interactions.

Dr. Joshua Woodward's research lab at the University of Washington focuses on understanding how the bacterium Listeria monocytogenes causes infections, particularly by colonizing the gallbladder. This lab investigates the unique environment of the gallbladder, which can harbor various pathogens, to identify which genes and biological pathways enable Listeria to thrive there. The findings could lead to new strategies for preventing the spread of this and other foodborne infections.

Dr. Nisha Jain Garg's lab focuses on understanding the molecular mechanisms behind Chagas disease, particularly how certain proteins affect heart function during the disease. By studying how the splicing of specific genes changes during infection, the lab aims to find new therapeutic strategies that could improve heart health in patients affected by Chagas. Their work bridges molecular biology and cardiology, aiming to offer insights into potential treatments for this serious condition.

Dr. Wendy S. Garrett's lab at Harvard University focuses on understanding the role of the gut microbiome, particularly the bacterium Fusobacterium nucleatum, in colorectal cancer (CRC). The team investigates how specific bacterial activities contribute to CRC progression, response to therapy, and overall cancer susceptibility. By exploring the interactions between F. nucleatum and immune cells, the lab aims to uncover mechanisms that may apply to various cancers beyond CRC.